Deepak Sampath

Person

San Francisco, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Combination therapy of a type II anti-CD20 antibody with a selectiv...
- Patent number 11,590,128
- Issue date Feb 28, 2023
- Genentech, Inc.
- Deepak Sampath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy of a type II anti-CD20 antibody with a selectiv...
- Patent number 11,413,282
- Issue date Aug 16, 2022
- Genentech, Inc.
- Deepak Sampath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy of a type II anti-CD20 antibody with a selectiv...
- Patent number 11,110,087
- Issue date Sep 7, 2021
- Genentech, Inc.
- Deepak Sampath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy of a type II anti-CD20 antibody with a selectiv...
- Patent number 10,993,942
- Issue date May 4, 2021
- Genentech, Inc.
- Deepak Sampath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination of Bcl-2 inhibitor and MEK inhibitor for the treatment...
- Patent number 10,959,993
- Issue date Mar 30, 2021
- Genentech, Inc.
- Mark Merchant
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy with an anti-HER2 antibody-drug conjugate and a...
- Patent number 10,898,570
- Issue date Jan 26, 2021
- Genentech, Inc.
- Gail Lewis Phillips
- G01 - MEASURING TESTING
Information Patent Grant
Combinations of AKT inhibitor compounds and chemotherapeutic agents...
- Patent number 10,092,567
- Issue date Oct 9, 2018
- Genentech, Inc.
- Kui Lin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods and compositions for modulating estrogen receptor mutants
- Patent number 9,855,270
- Issue date Jan 2, 2018
- Genentech, Inc.
- Jeffrey J. Hager
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combinations of AKT inhibitor compounds and chemotherapeutic agents...
- Patent number 9,717,730
- Issue date Aug 1, 2017
- Genentech, Inc.
- Kui Lin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combinations of AKT and MEK inhibitor compounds, and methods of use
- Patent number 9,682,082
- Issue date Jun 20, 2017
- Genentech, Inc.
- Brian Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combinations of AKT inhibitor compounds and erlotinib, and methods...
- Patent number 9,610,289
- Issue date Apr 4, 2017
- Genentech, Inc.
- Michelle Nannini
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy of a type II anti-CD20 antibody with a selectiv...
- Patent number 9,539,251
- Issue date Jan 10, 2017
- Genentech, Inc.
- Deepak Sampath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combinations of AKT inhibitor compounds and abiraterone, and method...
- Patent number 9,346,789
- Issue date May 24, 2016
- Genentech, Inc.
- Michelle Nannini
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combinations of AKT inhibitor compounds and erlotinib, and methods...
- Patent number 9,150,549
- Issue date Oct 6, 2015
- Genentech, Inc.
- Michelle Nannini
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Mutant selectivity and combinations of a phosphoinositide 3-kinase...
- Patent number 9,107,926
- Issue date Aug 18, 2015
- Genentech, Inc.
- Marcia Belvin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combinations of phosphoinositide 3-kinase inhibitor compounds chemo...
- Patent number 8,604,014
- Issue date Dec 10, 2013
- Genentech, Inc.
- Marcia Belvin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combinations of phosphoinositide 3-kinase inhibitor compounds and c...
- Patent number 8,247,397
- Issue date Aug 21, 2012
- Genentech, Inc.
- Marcia Belvin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...
- Publication number 20250152582
- Publication date May 15, 2025
- Genentech, Inc.
- Deepak Sampath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY WITH AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND A...
- Publication number 20250121058
- Publication date Apr 17, 2025
- Genentech, Inc.
- Gail Lewis Phillips
- G01 - MEASURING TESTING
Information Patent Application
COMBINATION THERAPY WITH AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND A...
- Publication number 20240277838
- Publication date Aug 22, 2024
- Genentech, Inc.
- Gail Lewis Phillips
- G01 - MEASURING TESTING
Information Patent Application
COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...
- Publication number 20240180901
- Publication date Jun 6, 2024
- Genentech, Inc.
- Deepak Sampath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...
- Publication number 20240108616
- Publication date Apr 4, 2024
- Genentech, Inc.
- Deepak Sampath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...
- Publication number 20240000776
- Publication date Jan 4, 2024
- Genentech, Inc.
- Deepak Sampath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...
- Publication number 20230255959
- Publication date Aug 17, 2023
- Genentech, Inc.
- Deepak Sampath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...
- Publication number 20230226045
- Publication date Jul 20, 2023
- Genentech, Inc.
- Deepak Sampath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...
- Publication number 20220370441
- Publication date Nov 24, 2022
- Genentech, Inc.
- Deepak Sampath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...
- Publication number 20220265642
- Publication date Aug 25, 2022
- Genentech, Inc.
- Deepak Sampath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...
- Publication number 20220211696
- Publication date Jul 7, 2022
- Genentech, Inc.
- Deepak Sampath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...
- Publication number 20220008413
- Publication date Jan 13, 2022
- Genentech, Inc.
- Deepak Sampath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY WITH AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND A...
- Publication number 20210213130
- Publication date Jul 15, 2021
- Genentech, Inc.
- Gail Lewis Phillips
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...
- Publication number 20210177838
- Publication date Jun 17, 2021
- Genentech, Inc.
- Deepak Sampath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF BCL-2 INHIBITOR AND MEK INHIBITOR FOR THE TREATMENT...
- Publication number 20210169865
- Publication date Jun 10, 2021
- Genentech, Inc.
- Mark Merchant
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...
- Publication number 20200253963
- Publication date Aug 13, 2020
- Genentech, Inc.
- Deepak Sampath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF BCL-2 INHIBITOR AND MEK INHIBITOR FOR THE TREATMENT...
- Publication number 20180303815
- Publication date Oct 25, 2018
- Genentech, Inc.
- Mark Merchant
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR TREATING CANCER USING PD-1 AXIS ANTAGO...
- Publication number 20180280505
- Publication date Oct 4, 2018
- Genentech, Inc.
- Sairy Hernandez
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MUTANT SELECTIVITY AND COMBINATIONS OF A PHOSPHOINOSITIDE 3-KINASE...
- Publication number 20180280408
- Publication date Oct 4, 2018
- Genentech, Inc.
- Marcia Belvin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY WITH AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND A...
- Publication number 20180140700
- Publication date May 24, 2018
- Genentech, Inc.
- Gail Lewis Phillips
- G01 - MEASURING TESTING
Information Patent Application
COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...
- Publication number 20170281619
- Publication date Oct 5, 2017
- Genentech, Inc.
- Deepak Sampath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATIONS OF AKT INHIBITOR COMPOUNDS AND CHEMOTHERAPEUTIC AGENTS...
- Publication number 20170157124
- Publication date Jun 8, 2017
- Genentech, Inc.
- Kui Lin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATMENT WITH TASELISIB
- Publication number 20160375033
- Publication date Dec 29, 2016
- Genentech, Inc.
- Kyle Edgar
- G01 - MEASURING TESTING
Information Patent Application
COMBINATIONS OF A PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUND AND...
- Publication number 20160279142
- Publication date Sep 29, 2016
- Genentech, Inc.
- Lori Friedman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMBINATIONS OF AKT INHIBITOR COMPOUNDS AND CHEMOTHERAPEUTIC AGENTS...
- Publication number 20160228440
- Publication date Aug 11, 2016
- Genentech, Inc.
- Kui Lin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR TREATING CANCER USING PD-1 AXIS ANTAGO...
- Publication number 20160158360
- Publication date Jun 9, 2016
- Genentech, Inc.
- Sairy Hernandez
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATIONS OF AKT INHIBITOR COMPOUNDS AND ERLOTINIB, AND METHODS...
- Publication number 20160051550
- Publication date Feb 25, 2016
- Genentech, Inc.
- Michelle Nannini
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MUTANT SELECTIVITY AND COMBINATIONS OF A PHOSPHOINOSITIDE 3-KINASE...
- Publication number 20160045515
- Publication date Feb 18, 2016
- Genentech, Inc.
- Marcia Belvin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
THERAPEUTIC COMBINATIONS WITH ESTROGEN RECEPTOR MODULATORS
- Publication number 20150258080
- Publication date Sep 17, 2015
- Genentech, Inc.
- Jeffrey J. Hager
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR MODULATING ESTROGEN RECEPTOR MUTANTS
- Publication number 20150258099
- Publication date Sep 17, 2015
- Genentech, Inc.
- Jeffrey J. Hager
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Deepak Sampath

Person

Patents Grantslast 30 patents

Combination therapy of a type II anti-CD20 antibody with a selectiv...

Combination therapy of a type II anti-CD20 antibody with a selectiv...

Combination therapy of a type II anti-CD20 antibody with a selectiv...

Combination therapy of a type II anti-CD20 antibody with a selectiv...

Combination of Bcl-2 inhibitor and MEK inhibitor for the treatment...

Combination therapy with an anti-HER2 antibody-drug conjugate and a...

Combinations of AKT inhibitor compounds and chemotherapeutic agents...

Methods and compositions for modulating estrogen receptor mutants

Combinations of AKT inhibitor compounds and chemotherapeutic agents...

Combinations of AKT and MEK inhibitor compounds, and methods of use

Combinations of AKT inhibitor compounds and erlotinib, and methods...

Combination therapy of a type II anti-CD20 antibody with a selectiv...

Combinations of AKT inhibitor compounds and abiraterone, and method...

Combinations of AKT inhibitor compounds and erlotinib, and methods...

Mutant selectivity and combinations of a phosphoinositide 3-kinase...

Combinations of phosphoinositide 3-kinase inhibitor compounds chemo...

Combinations of phosphoinositide 3-kinase inhibitor compounds and c...

Patents Applicationslast 30 patents

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...

COMBINATION THERAPY WITH AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND A...

COMBINATION THERAPY WITH AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND A...

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...

COMBINATION THERAPY WITH AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND A...

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...

COMBINATION OF BCL-2 INHIBITOR AND MEK INHIBITOR FOR THE TREATMENT...

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...

COMBINATION OF BCL-2 INHIBITOR AND MEK INHIBITOR FOR THE TREATMENT...

METHODS AND COMPOSITIONS FOR TREATING CANCER USING PD-1 AXIS ANTAGO...

MUTANT SELECTIVITY AND COMBINATIONS OF A PHOSPHOINOSITIDE 3-KINASE...

COMBINATION THERAPY WITH AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND A...

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...

COMBINATIONS OF AKT INHIBITOR COMPOUNDS AND CHEMOTHERAPEUTIC AGENTS...

METHODS OF TREATMENT WITH TASELISIB

COMBINATIONS OF A PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUND AND...

COMBINATIONS OF AKT INHIBITOR COMPOUNDS AND CHEMOTHERAPEUTIC AGENTS...

METHODS AND COMPOSITIONS FOR TREATING CANCER USING PD-1 AXIS ANTAGO...

COMBINATIONS OF AKT INHIBITOR COMPOUNDS AND ERLOTINIB, AND METHODS...

MUTANT SELECTIVITY AND COMBINATIONS OF A PHOSPHOINOSITIDE 3-KINASE...

THERAPEUTIC COMBINATIONS WITH ESTROGEN RECEPTOR MODULATORS

METHODS AND COMPOSITIONS FOR MODULATING ESTROGEN RECEPTOR MUTANTS